InsidersTradesSigma
Discover the complete record of transactions filed by MENDLEIN JOHN, Director. Director active across 1 companies, notably Fate Therapeutics INC. Cumulatively, 5 disclosures have been recorded. Total volume traded: €29k. The latest transaction was filed on 9 June 2022 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
5 of 5 declarations
John Mendlein serves as a board member at FATE THERAPEUTICS INC. He contributes to the strategic direction of the company, ensuring that decisions made within the board align with growth objectives. His expertise in biotechnology is a valuable asset.